» Articles » PMID: 10527690

Expression of Extracellular Matrix Ligands and Receptors in the Muscular Tissue and Draining Lymph Nodes of Mdx Dystrophic Mice

Overview
Journal Clin Immunol
Date 1999 Oct 21
PMID 10527690
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The mdx mouse, an animal model of Duchenne muscular dystrophy, develops an X-linked recessive inflammatory myopathy. During onset of disease and height of myonecrosis, mdx mice also display important changes in the microenvironment of lymphoid tissues. Draining lymph nodes showed reduced cellularity and atrophy accompanied by intense immunolabeling for fibronectin, laminin, and type-IV collagen. Following clinical amelioration of dystrophy, mdx mice showed enhanced cellularity and a consistent increase in the absolute numbers of CD4(+) and CD8(+) cells expressing alpha4(high) and alpha5(high) extracellular matrix receptors. Furthermore, infiltrating cells in the proximity of myonecrosis expressed alpha4, alpha5, and alpha6 integrin chains during both height of myonecrosis and muscular tissue regeneration. Such results indicate that during distinct phases of muscular dystrophy, altered expression of extracellular matrix ligands and receptors may be influencing myonecrosis by promoting adhesion and migration of mononuclear cells into the altered skeletal muscle and toward local draining lymphoid tissue.

Citing Articles

A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice.

Woodcock I, Tachas G, Desem N, Houweling P, Kean M, Emmanuel J PLoS One. 2024; 19(1):e0294847.

PMID: 38271438 PMC: 10810432. DOI: 10.1371/journal.pone.0294847.


CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Pinto-Mariz F, Rodrigues Carvalho L, Araujo A, de Mello W, Ribeiro M, Cunha M Skelet Muscle. 2015; 5:45.

PMID: 26664665 PMC: 4674917. DOI: 10.1186/s13395-015-0066-2.


Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Evans N, Misyak S, Robertson J, Bassaganya-Riera J, Grange R PM R. 2009; 1(8):755-68.

PMID: 19695529 PMC: 2779711. DOI: 10.1016/j.pmrj.2009.04.010.


Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice.

Salimena M, Lagrota-Candido J, Quirico-Santos T Histochem Cell Biol. 2004; 122(5):435-44.

PMID: 15452719 DOI: 10.1007/s00418-004-0707-8.


Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production.

Lagrota-Candido J, Vasconcellos R, Cavalcanti M, Bozza M, Savino W, Quirico-Santos T Int J Exp Pathol. 2002; 83(3):121-32.

PMID: 12383191 PMC: 2517677. DOI: 10.1046/j.1365-2613.2002.00221.x.